The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Therapy Medicinal Products (GTMP) Market Research Report 2024
Synopsis
The global Gene Therapy Medicinal Products (GTMP) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Medicinal Products (GTMP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Medicinal Products (GTMP).
Report Scope
The Gene Therapy Medicinal Products (GTMP) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy Medicinal Products (GTMP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy Medicinal Products (GTMP) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Segment by Type
Oral
Injection
Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy Medicinal Products (GTMP) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Gene Therapy Medicinal Products (GTMP) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Medicinal Products (GTMP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Medicinal Products (GTMP).
Report Scope
The Gene Therapy Medicinal Products (GTMP) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy Medicinal Products (GTMP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy Medicinal Products (GTMP) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Segment by Type
Oral
Injection
Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy Medicinal Products (GTMP) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicinal Products (GTMP) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Medicinal Products (GTMP) Market Perspective (2019-2030)
2.2 Gene Therapy Medicinal Products (GTMP) Growth Trends by Region
2.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy Medicinal Products (GTMP) Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy Medicinal Products (GTMP) Market Dynamics
2.3.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
2.3.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
2.3.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
2.3.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue
3.1.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Medicinal Products (GTMP) Revenue
3.4 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio
3.4.1 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicinal Products (GTMP) Revenue in 2023
3.5 Gene Therapy Medicinal Products (GTMP) Key Players Head office and Area Served
3.6 Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
3.7 Date of Enter into Gene Therapy Medicinal Products (GTMP) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2025-2030)
5 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2019-2030)
6.2 North America Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024)
6.4 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2019-2030)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024)
7.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2019-2030)
9.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Detail
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Detail
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Detail
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Detail
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Detail
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Detail
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Detail
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Detail
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
11.8.5 Advantagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2019-2024)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2025-2030)
Table 10. Gene Therapy Medicinal Products (GTMP) Market Trends
Table 11. Gene Therapy Medicinal Products (GTMP) Market Drivers
Table 12. Gene Therapy Medicinal Products (GTMP) Market Challenges
Table 13. Gene Therapy Medicinal Products (GTMP) Market Restraints
Table 14. Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players (2019-2024)
Table 16. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2023)
Table 17. Ranking of Global Top Gene Therapy Medicinal Products (GTMP) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
Table 21. Date of Enter into Gene Therapy Medicinal Products (GTMP) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2019-2024)
Table 25. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2025-2030)
Table 27. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2019-2024)
Table 29. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2025-2030)
Table 31. North America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bluebird Bio Company Detail
Table 47. Bluebird Bio Business Overview
Table 48. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product
Table 49. Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 50. Bluebird Bio Recent Development
Table 51. Sangamo Company Detail
Table 52. Sangamo Business Overview
Table 53. Sangamo Gene Therapy Medicinal Products (GTMP) Product
Table 54. Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 55. Sangamo Recent Development
Table 56. Spark Therapeutics Company Detail
Table 57. Spark Therapeutics Business Overview
Table 58. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 59. Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 60. Spark Therapeutics Recent Development
Table 61. Dimension Therapeutics Company Detail
Table 62. Dimension Therapeutics Business Overview
Table 63. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 64. Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 65. Dimension Therapeutics Recent Development
Table 66. Avalanche Bio Company Detail
Table 67. Avalanche Bio Business Overview
Table 68. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product
Table 69. Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 70. Avalanche Bio Recent Development
Table 71. Celladon Company Detail
Table 72. Celladon Business Overview
Table 73. Celladon Gene Therapy Medicinal Products (GTMP) Product
Table 74. Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 75. Celladon Recent Development
Table 76. Vical Inc. Company Detail
Table 77. Vical Inc. Business Overview
Table 78. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product
Table 79. Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 80. Vical Inc. Recent Development
Table 81. Advantagene Company Detail
Table 82. Advantagene Business Overview
Table 83. Advantagene Gene Therapy Medicinal Products (GTMP) Product
Table 84. Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2019-2024) & (US$ Million)
Table 85. Advantagene Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Gene Therapy Medicinal Products (GTMP) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Monogenic Case Studies
Figure 9. Infectious Disease Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Other Case Studies
Figure 12. Gene Therapy Medicinal Products (GTMP) Report Years Considered
Figure 13. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region: 2023 VS 2030
Figure 16. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players in 2023
Figure 17. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue in 2023
Figure 19. North America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2019-2030)
Figure 21. United States Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Country (2019-2030)
Figure 25. Germany Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2019-2030)
Figure 33. China Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2019-2030)
Figure 41. Mexico Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Country (2019-2030)
Figure 45. Turkey Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 48. Sangamo Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 49. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 50. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 51. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 52. Celladon Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 53. Vical Inc. Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 54. Advantagene Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
